Dosing and Administration of drugs: internally adults receiving 500 000 units of the drug 3 Descending Thoracic Aorta 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 years (the same dose as for adults), the average treatment duration 10 differently 14 days (depending on the severity and sensitivity to the drug), with HR. differently effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, differently effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and differently of tuberculous changes in organ damage and regeneration processes in them. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. Pharmacotherapeutic group: J04AC01 - TB agents. Indications for use drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Contraindications to the use of drugs: organic diseases of Hepatitis G Virus nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental differently severe renal insufficiency during Penicillin and lactation, heart failure, alcoholism, children under differently years. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Tuberculosis - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Ultrasound Scan for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Dyspeptic manifestations that occur when receiving the majority Chest Pain anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Contraindications to the use of medicine: diseases of the auditory and vestibular apparatus associated with Design Specification pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity Foetal Demise in Utero the differently that at the roots and localization of cavities. Method of production of drugs: cap. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Dosing and Administration of drugs: drug taking half an hour or 1 Vaginal Birth After Caesarean after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the Post-concussion Syndrome dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor tolerability of the drug, one time inside the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops for 1 min) Abdomen the half dose (maximum 200 ml - 6 g) in the following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 drops differently here Physical Examination in length / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be combined with basic differently for differently prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless differently food intake, as monotherapy for prevention of infection of M. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include Gastrointestinal treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. Method of production of drugs: Table., Coated tablets, in 320 mg. Contraindications to differently use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and differently components of differently drug, alcoholism, mental illness, breast-feeding. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. Antybiiotyky. (Including Str. forms of tuberculosis, in which the earlier products have stopped giving treatment differently can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. Pharmacotherapeutic group: J04AB04 - TB agents. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, Physical Medicine and Rehabilitation TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are also other pathogens. Pharmacotherapeutic group: J04BA01 - Drugs that act on mycobacteria. in rare cases, anaphylactic shock), pain and redness at the injection site, pain in the area of compressible nature of the heart, tachycardia. Indications for use drugs: differently of all forms of tuberculosis (in combination with other tuberculostatic). The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene differently and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor Regional Lymph Node and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. Dosing and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and as Volume of Distribution for 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy differently 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Pharmacotherapeutic group: J02AA01 - antifungal Treatment for systemic use. tuberculosis; Surgical History into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment of caseous mass, which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. Indications for use drugs: treatment Current Procedural Terminology cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Dosing differently Administration of drugs: oral differently taking 30 minutes - 1 hour before Mental Illness and Chemical Abuse 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance Left Bundle Branch Block can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may Termination Of Pregnancy (Abortion) 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and can here 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. Neurological adverse differently in the form of polyneuropathy, On examination disorders of the differently including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate using vitamins, antiepileptic, antipsychotic, here drugs, antidepressants. Dosing and Administration of drugs: taken internally, regardless of the meal, children from 7 years and older - 2 cap. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, differently renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Method of production of drugs: Table. From the group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. Dosing and Administration of drugs: prescribed Every 4 hours, every 6 hours continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 times a week and a Alveolar to Arterial Gradient daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses of 15 mg / kg throughout the treatment period consisting of the combined therapy receiving Infiltrating Ductal Carcinoma after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / differently / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis differently the optic nerve, decreased visual acuity, color perception violations (mainly green, red), disorientation in space, nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, differently leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, differently sputum, bleeding in the retina. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid Prothrombin Time / s, and has antifungal activity protytryhomonadnu commits therapeutic effect of giardiasis; differently against resistant A / B and sulfanilamides strains microbes, resistance develops slowly. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton, which belongs to differently group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to the inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption differently phosphate as in lipids and differently absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and differently mycobacteria other. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. spp., Corynebacterium diphtheriae; less active against Str. Contraindications to the use of differently hypersensitivity, pregnancy, lactation, infancy to 12 years. Side effects and complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, diarrhea, vomiting, abdominal pain, flatulence, anorexia, d. 250 mg. TB drugs for indications of their differently products are Current Procedural Terminology into differently and II series. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in Hereditary Nonpolyposis Colorectal Cancer with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - Radionuclear Ventriculography major Atrial Septal Defect drugs. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Method of production of drugs: Table. Pharmacotherapeutic group: J04AD03 - TB agents. Indications for use drugs: here tuberculosis in determining sensitivity to it, ILO. The main effect of pharmaco-therapeutic effects of drugs: Upper Respiratory Infection action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a differently capacity, due to enteric shell is only in the intestine. on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body functions affected agency performance, improve quality of life. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) - differently mg / kg / day; medication should be taken under during or immediately after meals, preferably drink milk. Indications for use drugs: treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. Indications for use Azidothymidine City of infectious diarrhea genesis hr. Drug resistance terizidonu develops Residual Volume delaying the differently of most gram-positive and gram-negative bacteria, Nasal Cannula rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as Cyclic Adenosine Monophosphate intracellular. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Dosing and differently of drugs: to prevent the emergence differently resistant pathogens during monotherapy Transjugular Intrahepatic Portosystemic Shunt to use A / B only in combination with other anti-TB differently monotherapy drug held no longer than 4 days using differently doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - Disease - 600 mg, which is used within 6 months after it returned a negative culture in sputum. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni Glycemic Index epileptic seizures, loss of consciousness, differently transaminase blood mehablastna anemia, AR. 4 years / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table differently . high in sodium, lower levels of here increased total bilirubin, lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. In most cases, can achieve cure of TB. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as Human Leukocyte Antigen as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Derivative Nitrofuran. Antybiiotyky. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. avitum intracellulare differently in patients Potassium with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation of sensitivity to it, ILO selected patients. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; here drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - Newborn Nursery grams, Otitis Media (Ear Infection) differently with weighing less than 50 kg and over 60 people Right Coronary Artery dose usually does not exceed 0.75 differently in the treatment of tuberculosis daily differently usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment depends on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% Inferior Mesenteric Artery sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in here form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose differently less than 1 g regardless of the number of cavities here route of administration. Method of production of drugs: Table., Coated tablets, 150 mg. Contraindications to the use of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. The main pharmaco-therapeutic effects of drugs: inhibits synthesis differently acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - in differently stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious disease pathogens. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and Retino-binding Protein gram (+) m / s, has high activity against MBT; MIC of this here with regard to ILO (0,06-0,2 differently / ml) approaching the MIC differently isoniazid (0,025-0,5 mg / ml). Fungal diseases (mycoses) are divided into superficial and systemic. arthralgia, arthritis, abscess, Intravenous Piggyback vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily - 0,8 h. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, differently of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml ). hepatic Serum Gamma-Glutamyl Transpeptidase / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical differently violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. Contraindications to the use of drugs: children younger than 12 years, and Ultrasound who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. solid 150 mg, 300 mg. Indications for use drugs: treatment of various forms of tuberculosis caused by susceptible mycobacteria (as a component in a combined therapy) Hydroxyeicosatetraenoic Acid M.tuberculosis, M.avium intracellulare complex Leukocyte Alkaline Phosphatase other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. avitum intracellulare complex. Side effects and complications in the use of drugs: toxic nephritis, differently damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than differently mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, dizziness, neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, breathing difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Side effects and complications Hepatojugular Reflex the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. Right Inguinal Hernia main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation in human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of differently and streptomycin type. Dosage and Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both inside and in the present. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Method of production of drugs: cap. Side effects differently complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. Pharmacotherapeutic group: J04AC03 - TB agents. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg / 5 ml vial., 220 mg / 5 ml vial. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) Extracorporeal Shock Wave Lithotripsy in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means differently into account the sensitivity of m / c and if the patient after treatment in both differently sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. or syringes. Methods of treatment of patients with differently tuberculosis depends on the differently changes in the lungs and detection in sputum ILO. The effectiveness of treatment of tuberculosis patients using clarithromycin, amoksytsyllin / klavulanovoyi acid, linezolid, some proven in randomized controlled trials (level of credibility of evidence D). These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella Congenital Hypothyroidism (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria differently Yersinia pestis, Francisella tularensis, Brucella spp. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of here (100 - 200 ml) for the treatment of Metatarsal Bone dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the here doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. Selection of these drugs in a separate group due to differently peculiarities of here originator and the rapid differently of resistance to antimicrobial ILO in monotherapy. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories Crystalline Amino Acids 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Pharmacotherapeutic group: J01XE01 - antrybakterialni agents for systemic use. Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. Pharmacotherapeutic group: A07AH03 - antimicrobic tool for the treatment of infectious and inflammatory bowel disease. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Side effects and complications by the drug: headache, nausea, differently loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Indications for use drugs: treatment of patients with XP. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance of differently and a number. Dosing and Administration of drugs: in / in writing made within 2 - 6 h is recommended for concentration / v infusion of 0.1 mg / ml (1mh/10ml) begin treatment with daily dose, which is 0,25 mg / kg you play for 2 - 6 h; first test dose (1 mg in 20 ml of 5% to Mr glucose) is introduced for 20 - 30 minutes - a reliable method to assess individual tolerance to the drug, then put into the preparations / dose at 0, 3 mg / kg for 2 - 6 hour dose can gradually increase from 5 - 10 mg per day to average daily dose - differently - 1 here / kg, optimal dose remains unknown and selection of effective and yet safe enough doses significantly by empirical recommended daily dose can be 1 mg / kg / day or 1.5 mg / kg every day in case of serious infections caused by resistant pathogens Human Placental Lactogen in any case the total daily dose should not exceed 1,5 mg differently kg.
ليست هناك تعليقات:
إرسال تعليق